CDXS: Codexis Inc. Company Profile & Statistics

About

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis? proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.

Info & Links

CEO

Stephen Dilly

Headquarters

200 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

125

Employees

174

Codexis Inc. Statistics

Valuation Measures

Market Capitalization²

408.93M

Enterprise Value

399.60M

Enterprise Value/EBITDA(ttm)

-9.12

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.54

Price to Book(mrq)

4.87

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

70.94%

Operating Margin(ttm)

-83.48%

Profit Margin(ttm)

-135.12%

Return on Equity(ttm)

-71.56%

Return on Invested Capital(ttm)

-64.58%

Return on Assets(ttm)

-38.00%

Income Statement

Revenue(ttm)

64.45M

Revenue Per Share(ttm)

0.79

Gross Profit(ttm)

48.95M

EBITDA(ttm)³

-43.83M

Net Income Available to Common(ttm)

-62.09M

Diluted EPS(ttm)

-0.87

Share Statistics

Beta (5Y Monthly)

2.13

52-Week Change

108.51%

S&P 500 52-Week Change

23.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

81.38M

Dividend Yield

0.00%

Float⁴

79.67M

% Held by Insiders

2.10%

% Held by Institutions

78.54%

Balance Sheet

Total Cash(mrq)

90.77M

Total Cash Per Share(mrq)

1.12

Total Debt(mrq)

28.63M

Total Debt/Equity(mrq)

39.01%

Current Ratio(mrq)

3.21%

Quick Ratio(mrq)

3.15%

Book Value Per Share(mrq)

0.90

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.46

Free Cash Flow(ytd)

-35.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CDXS

Codexis Inc.

Codexis Inc. Profile